Why It Matters
Rhode Island’s medical research community is receiving a significant funding boost, with nearly $650,000 in grants supporting 26 projects ranging from diabetes prevention to next-generation antibiotic development. The awards signal growing institutional investment in the state’s research capacity — and highlight how artificial intelligence is increasingly entering high-stakes clinical settings like cancer diagnostics.
What Happened
The Rhode Island Foundation announced Monday it would distribute grants to 26 state-based medical research projects. Among the recipients is Alina Jade Barnett, an assistant professor of computer science and statistics at the University of Rhode Island (URI), whose work focuses on improving how AI models reason through breast cancer diagnoses.
Barnett’s project addresses a specific and consequential flaw in AI diagnostic tools: models that arrive at correct answers through incorrect reasoning — identifying cancer in the wrong region of an image, or developing biases based on the imaging equipment used at a particular hospital.
“Sometimes the AI gets the right answer for the wrong reason,” Barnett said in public remarks. Her funded research centers on developing methods to correct that reasoning without disrupting the broader system — a problem she describes as requiring specialized solutions rather than manual fixes.
URI received 14 of the 26 grants, accounting for the largest share of the total award pool. Rhode Island Hospital was awarded six grants, while The Miriam Hospital received three. Brown University, Johnson & Wales University, and Providence College each received one grant.
By the Numbers
- $650,000 — approximate total grant funding distributed across all 26 projects
- 26 — number of Rhode Island medical research projects receiving awards
- $25,000 — standard award amount for most individual grants, including Barnett’s
- 14 — grants awarded to URI-based projects, representing more than half the total
- 6 — grants directed to Rhode Island Hospital research teams
The AI Diagnostic Challenge
Barnett, who specializes in machine learning and healthcare-centric AI, has focused her career on understanding the internal reasoning processes of AI systems — a field that becomes critical when those systems are used in life-or-death decisions.
She describes two distinct failure modes in AI cancer detection. In the first, the model correctly identifies a malignancy but flags the wrong area of the image. In the second, training data imbalances cause a model to associate irrelevant variables — such as the type of imaging equipment used — with a diagnosis, rather than the actual medical indicators.
As an example, a model trained primarily on scans from one imaging brand may interpret data differently when exposed to a competitor’s equipment, even within the same hospital system. Barnett notes that identifying these errors is often simpler than correcting them: adjusting a model’s reasoning requires specialized techniques that don’t compromise the rest of its functions.
The grant funding will support graduate student research time over the summer, along with travel and conference costs that allow Barnett’s team to present findings to breast cancer researchers and collaborate with radiologists who can assess whether corrections to the model’s reasoning actually improve outcomes.
Barnett’s work remains at the foundational research stage and is not currently integrated into any commercial diagnostic software.
Broader Research Topics
Beyond AI diagnostics, the grant slate covers a wide range of health challenges. Funded projects include research into concussion treatment for adolescents, the patient experience of GLP-1 weight-loss medications, diabetes prevention strategies, and the development of new antibiotic compounds derived from microorganisms found in marine mollusks.
David Cicilline, the foundation’s president and CEO, noted in a statement that while the individual grants are modest in size, they are intended to catalyze larger investments. “They can lead to big discoveries that will spark substantial new investments in the state’s research sector,” he said.
What’s Next
Barnett’s team plans to use the summer funding period to advance the technical groundwork and begin sharing results with medical collaborators. A full list of grant recipients and their research projects is being made available through the Rhode Island Foundation.
The foundation’s grant program reflects a national push to expand regional medical research infrastructure. Federal health agencies and private foundations have increasingly directed seed funding toward state-level institutions, aiming to build pipelines that attract larger clinical and commercial investments — a trend relevant to ongoing federal efforts to reform healthcare delivery and reduce administrative friction in medical decision-making. Rhode Island’s grant cycle also comes as the state weighs broader economic development strategies, including proposals to stimulate growth in Providence through targeted tax stabilization measures.